课题基金 / 基金详情

T32 CTEng (Cellular and Tissue Engineering) Training Program

T32 CTEng (Cellular and Tissue Engineering) Training Program
T32 CTEng(细胞和组织工程)培训计划
批准号:
10420388
负责人:
Edward A. Botchwey
金额:
$46.83万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-06-30

项目摘要

项目成果

Edward A. Botchwey的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 这项申请要求为我们高度成功和有影响力的NIGMS的31-35年提供资金 细胞和组织工程生物技术T32计划(CTEng)。CTEng的目标是 为在读博士后的工科学生提供创新的综合训练 组织工程,为这些生物技术行业培养未来的领导者。CTEng将 提供创新的综合培训方案,包括:(I)正规工程课程 基础、生物科学、生物工程和商业原理;(Ii)与教职员工每两周举行一次会议 主题在期刊俱乐部讨论、研究演示、教师和行业职业生涯之间轮流 讨论和辅导培训;(3)工业访问和实习;(3)一名行业导师 计划;(Iv)年度细胞和组织工程会议;(V)区域T32生物技术职业 发展讲习班;和(6)负责任地进行研究和方法方面的培训 提高再现性。佐治亚理工学院提供卓越、高度协作和集成的 细胞和组织工程方面的培训和研究环境。特别的优势,以及在许多方面 我们项目的独特之处包括:(1)全国最大的学院之一, 由许多细胞和组织工程领域的领先研究人员组成,他们提供了一种动态的, 广泛而深厚的专业知识;(2)在工程和医学方面公认的领导地位(具有 我们的合作伙伴埃默里大学医学院),特别是在他们的交叉点;(3)杰出 研究设施和基础设施;(4)创新培训部分的课程,强调 培养具有强大领导力和沟通能力的跨学科研究人员;(5)充满活力 具有多方面连接点的生态系统可连接到行业和创业以及 商业化;(6)丰富多样和支持性的文化;以及(7)面向 招收、培训和毕业人数最少的少数族裔学生 在全国也是最成功的。CTEng导师将从我们的 生物工程,联合GT/Emory生物医学工程,化学和生物分子工程,以及 机械工程计划第一年结束时,CTEng将支持选定的 研究生院二年级和三年级的实习生。我们要求每年资助9名学生, 这是目前的资金水平。CTEng的毕业生将在以下方面表现出高研究生产率 出版和演示,并将过渡到有影响力的职业生涯在学术,工业和 并成为细胞和组织工程生物技术行业的领导者。
英文摘要
Project Summary This application requests funding for Years 31-35 of our highly successful and impactful NIGMS Biotechnology T32 Program on Cell and Tissue Engineering (CTEng). The objective of CTEng is to provide innovative and integrated training for predoctoral engineering students in cell and tissue engineering to develop future leaders for these biotechnology industries. CTEng will provide an innovative and integrated training program comprising (i) formal courses on engineering fundamentals, biosciences, bioengineering, and business principles; (ii) bi-weekly meetings with faculty with topics rotating among journal club discussion, research presentation, faculty and industry career discussions, and mentorship training; (iii) industrial visits and internships; (iii) an industry mentor program; (iv) an annual cell and tissue engineering conference; (v) a regional T32 Biotechnology career development workshop; and (vi) training in the responsible conduct of research and methods for enhancing reproducibility. Georgia Tech provides an outstanding, highly collaborative and integrative training and research environment in cell and tissue engineering. The particular strengths, and in many instances unique features, of our program include (1) one of the largest faculties in the nation, comprising many of the leading researchers in cell and tissue engineering, who provide a dynamic, broad and deep critical mass of expertise; (2) recognized leadership in engineering and medicine (with our partner Emory University School of Medicine) and especially at their intersection; (3) outstanding research facilities and infrastructure; (4) a curriculum of innovative training components emphasizing developing interdisciplinary researchers with strong leadership and communication skills; (5) a dynamic ecosystem with multi-faceted connection points to industry and entrepreneurship and commercialization; (6) a richly diverse and supportive culture; and (7) quality programs for the recruitment, training and graduation of underrepresented minority students that are among the largest and most successful in the nation. CTEng preceptors will nominate predoctoral students from our BioEngineering, joint GT/Emory Biomedical Engineering, Chemical and Biomolecular Engineering, and Mechanical Engineering programs at the end of their first year, and CTEng will support selected trainees for the second and third years of graduate school. We request support for 9 students per year, which is the current funding level. Graduates of CTEng will exhibit high research productivity in terms of publications and presentations and will transition into impactful careers in academic, industry, and government and become leaders of the cell and tissue engineering biotechnology industries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T32 CTEng (Cellular and Tissue Engineering) Training Program
  • 批准号:
    10641891
  • 项目类别:
  • 资助金额:
    $47.75万
  • 财政年份:
    2022
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
Artery biomechanics and vascular damage in sickle cell disease
  • 批准号:
    10390381
  • 项目类别:
  • 资助金额:
    $58.09万
  • 财政年份:
    2021
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
Artery biomechanics and vascular damage in sickle cell disease
  • 批准号:
    10606485
  • 项目类别:
  • 资助金额:
    $56.41万
  • 财政年份:
    2021
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
Regenerative Immunotherapy using light triggered in vivo activation of adhesive peptides
  • 批准号:
    10252435
  • 项目类别:
  • 资助金额:
    $42.99万
  • 财政年份:
    2020
  • 负责人:
    Edward A. Botchwey
  • 依托单位:
海外基金